Skip to main content
Euglena Co., Ltd. logo

Euglena Co., Ltd. — Investor Relations & Filings

Ticker · 2931 ISIN · JP3944370000 LEI · 529900OW9QKWU8LU7D52 T Manufacturing
Open in API
Filings indexed 78 across all filing types
Latest filing 2024-08-08 Interim / Quarterly Rep…
Country JP Japan
Listing T 2931

About Euglena Co., Ltd.

https://www.euglena.jp/en/

Euglena Co., Ltd. is a biotechnology company that pioneered the world's first successful outdoor mass cultivation of the edible microalgae, Euglena. The company's core activities are centered on a "Sustainability First" philosophy. Its Healthcare business develops and markets food and cosmetic products that utilize the 59 rich nutrients found in Euglena to support well-being. The Biofuel business focuses on the research, development, and production of next-generation sustainable fuels derived from sources including microalgae and used cooking oil. The company also actively enters new fields to promote social change and contribute to a sustainable society.

Recent filings

Filing Released Lang Actions
半期報告書－第20期(2024/01/01－2024/12/31)
Interim / Quarterly Report Classification · 100% confidence The document is a '第２四半期報告書' (Second Quarter Report) for Euglena Co., Ltd., covering the period from January 1, 2024, to June 30, 2024. It includes detailed financial statements, management analysis (MDA), and corporate information as required by the Financial Instruments and Exchange Act of Japan. This is a comprehensive interim financial report, not an announcement or a summary, and therefore fits the definition of an Interim/Quarterly Report (IR). H1 2024
2024-08-08 Japanese
確認書
Report Publication Announcement Classification · 100% confidence The document text contains a header indicating "第２四半期報告書" (Second Quarter Report) and explicitly mentions the period covered: "第20期中間期（自 2024年１月１日 至 2024年６月30日）" (20th Fiscal Period Interim Period (From Jan 1, 2024, to Jun 30, 2024)). It includes confirmation statements by the CEO and CFO regarding the appropriateness of the filing content based on the Financial Instruments and Exchange Act. This structure strongly indicates a comprehensive financial report for an interim period shorter than a year, which corresponds to the definition of an Interim / Quarterly Report (IR). The document length is very short (593 chars), but the content is the substance of the required confirmation for the interim report, not just an announcement of its publication. Therefore, IR is the most appropriate classification.
2024-08-08 Japanese
臨時報告書
Regulatory Filings Classification · 100% confidence The document is titled "臨時報告書" (Extraordinary Report/Timely Disclosure Report) and is submitted to the Kanto Local Finance Bureau Director (関東財務局長) on May 14, 2024. The filing reason explicitly states that it is submitted based on Article 24-5, Paragraph 4 of the Financial Instruments and Exchange Act, due to an event that significantly impacts the consolidated financial condition, operating results, and cash flow. The content details a specific event: the impairment loss recognized due to the sale of a subsidiary's shares, resulting in a special loss of 809 million yen in the first quarter consolidated financial statements. This structure—a formal, timely disclosure of a significant, non-periodic financial event (like a major impairment or asset sale) under Japanese regulations (FIEA)—is characteristic of an extraordinary report. In the provided classification scheme, this type of material, which is a specific regulatory disclosure outside of standard periodic reports (10-K, IR), best fits the general 'Regulatory Filings' category (RNS) or potentially a specific disclosure type if one existed for timely material event reports. Given the options, RNS (Regulatory Filings) is the most appropriate fallback for a specific, non-standard regulatory filing like this Japanese 'Timely Disclosure Report' that isn't an ER, 10-K, or IR.
2024-05-14 Japanese
確認書
Report Publication Announcement Classification · 100% confidence The document is titled "第１四半期報告書" (First Quarter Report) and explicitly states the reporting period: "第20期第１四半期（自 2024年１月１日 至 2024年３月31日）". It includes confirmation statements by the CEO and CFO regarding the appropriateness of the contents based on financial instruments laws ("金融商品取引法令"). This structure and content strongly indicate a comprehensive quarterly financial report, which corresponds to the definition of an Interim / Quarterly Report (IR). The document length is very short (598 chars), but the content is the core certification section of the report itself, not merely an announcement of its publication. Therefore, the classification is IR.
2024-05-13 Japanese
四半期報告書－第20期第1四半期(2024/01/01－2024/03/31)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (四半期報告書) for Euglena Co., Ltd. covering the first quarter of the 20th fiscal year (January 1, 2024, to March 31, 2024). It contains detailed financial statements, including the consolidated balance sheet, income statement, and comprehensive income statement, as well as management analysis. This fits the definition of an Interim/Quarterly Report (IR). Q1 2024
2024-05-13 Japanese
有価証券届出書（参照方式）
Share Issue/Capital Change Classification · 98% confidence The document explicitly states in the cover page and throughout the text that it is a "有価証券届出書" (Yūka Shōken Todokedesho), which translates to a Securities Registration Statement. This type of filing in Japan is used to register securities being offered to the public or allocated to specific parties, often related to capital changes or employee stock compensation plans, as detailed here (PSU and Employee Stock Compensation). In the context of US SEC filings equivalents, a Registration Statement (like S-1 or S-3) is the closest analogue for a new offering. However, among the provided Japanese/general filing codes, this document details a specific offering of shares (245,305 shares) to directors and employees as compensation, which is a form of capital/financing activity, but the document *itself* is the formal registration document required before the issuance. Since there is no specific code for a Japanese Securities Registration Statement, we must evaluate the closest fit. It is not a 10-K (Annual Report), ER (Earnings Release), or IR (Interim Report). It details a capital change (issuance of shares for compensation). The closest category that covers fundraising or capital structure changes is 'Capital/Financing Update' (CAP). However, the document's primary nature is the formal regulatory filing itself, detailing the offering terms, which often falls under a general regulatory category if a specific registration statement code is missing. Given the detailed nature of the offering and the explicit title '有価証券届出書', it is a formal regulatory filing concerning capital. Since 'CAP' covers updates on fundraising/financing activities, and this document registers the issuance of new shares for compensation, 'CAP' is a strong candidate. Alternatively, 'RNS' (Regulatory Filings) is the fallback. Because this is a comprehensive registration document detailing the mechanics of a share issuance (a financing event), 'CAP' is more specific than the general 'RNS'. I will classify it as CAP, as it is fundamentally a filing related to the issuance of capital.
2024-04-08 Japanese

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.